Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience.
Mohamed A, Asa SL, Lee Z, Tirumani SH, Li Q, Avril N, Bajor D, Mahipal A, Chakrabarti S, Selfridge JE, Kardan A. Mohamed A, et al. Among authors: avril n. J Gastrointest Oncol. 2023 Apr 29;14(2):1087-1094. doi: 10.21037/jgo-22-1011. Epub 2023 Mar 31. J Gastrointest Oncol. 2023. PMID: 37201086 Free PMC article. Review.
PET Imaging of Hepatocellular Carcinoma Using ZD2-(68Ga-NOTA).
Sergeeva O, Zhang Y, Gao S, Chan ER, Sergeev M, Iyer R, Sexton S, Avril N, Lu ZR, Lee Z. Sergeeva O, et al. Among authors: avril n. J Hepatocell Carcinoma. 2023 Feb 22;10:291-301. doi: 10.2147/JHC.S390939. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 36860804 Free PMC article.
Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
Deshpande SR, Podder TK, Grubb W, Zhang Y, Zheng Y, Towe C, Linden P, Avril N, Biswas T. Deshpande SR, et al. Among authors: avril n. Adv Radiat Oncol. 2023 Jul 9;9(1):101313. doi: 10.1016/j.adro.2023.101313. eCollection 2024 Jan. Adv Radiat Oncol. 2023. PMID: 38260218 Free PMC article.
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.
Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU; Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. Roy S, et al. Among authors: avril n. J Clin Oncol. 2023 Nov 10;41(32):5005-5014. doi: 10.1200/JCO.23.00617. Epub 2023 Aug 28. J Clin Oncol. 2023. PMID: 37639648 Free PMC article.
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF; LIGHTHOUSE Study Group. Surasi DS, et al. Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414702 Free article.
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT).
Jani AB, Ravizzini GC, Gartrell BA, Siegel BA, Twardowski P, Saltzstein D, Fleming MT, Chau A, Davis P, Chapin BF, Schuster DM; SPOTLIGHT Study Group. Jani AB, et al. J Urol. 2023 Aug;210(2):299-311. doi: 10.1097/JU.0000000000003493. Epub 2023 Apr 26. J Urol. 2023. PMID: 37126069
Abdominopelvic MR to CT registration using a synthetic CT intermediate.
Heo JU, Zhou F, Jones R, Zheng J, Song X, Qian P, Baydoun A, Traughber MS, Kuo JW, Helo RA, Thompson C, Avril N, DeVincent D, Hunt H, Gupta A, Faraji N, Kharouta MZ, Kardan A, Bitonte D, Langmack CB, Nelson A, Kruzer A, Yao M, Dorth J, Nakayama J, Waggoner SE, Biswas T, Harris E, Sandstrom S, Traughber BJ, Muzic RF Jr. Heo JU, et al. Among authors: avril n. J Appl Clin Med Phys. 2022 Sep;23(9):e13731. doi: 10.1002/acm2.13731. Epub 2022 Aug 3. J Appl Clin Med Phys. 2022. PMID: 35920116 Free PMC article.
The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs).
Mohamed A, Asa SL, McCormick T, Al-Shakhshir H, Dasari A, Mauricio R, Salem I, Ocuin LM, Bajor D, Lee RT, Selfridge JE, Kardan A, Lee Z, Avril N, Kopp S, Winter JM, Hardacre JM, Ammori JB, Ghannoum MA. Mohamed A, et al. Among authors: avril n. Curr Issues Mol Biol. 2022 Apr 30;44(5):2015-2028. doi: 10.3390/cimb44050136. Curr Issues Mol Biol. 2022. PMID: 35678665 Free PMC article.
119 results